Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 28851-28900 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05989763
Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
NA
Recruiting
60 participants
Started: Feb 17, 2024 · Completed: Sep 1, 2029
4 conditions
2 sponsors
1 location
NCT06265636
Electrical Stimulation of the Mandibular Nerve for Pain and Function Management in Temporomandibular Disorders
NA
Recruiting
40 participants
Started: Feb 17, 2024 · Completed: May 1, 2027
1 condition
2 sponsors
1 location
NCT06240637
Telemonitoring Utility in the Process of Adaptation to Home Mechanical Ventilation (HMV)
NA
Recruiting
48 participants
Started: Feb 17, 2024 · Completed: Dec 1, 2026
1 condition
3 sponsors
1 location
NCT06104956
Weaning Protocol for High-flow Nasal Oxygen Therapy in Intensive Care
NA
Recruiting
370 participants
Started: Feb 17, 2024 · Completed: Mar 31, 2027
2 conditions
1 sponsor
11 locations
NCT06304350
Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinoma
PHASE2
Recruiting
25 participants
Started: Feb 17, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06260839
the Effect of Minimally Invasive Technique Assisted by Magnetic Resonance Neurography
NA
Recruiting
44 participants
Started: Feb 16, 2024 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05595005
Neural Bases of Post-stroke Emotion Perception Disorders
N/A
Recruiting
80 participants
Started: Feb 16, 2024 · Completed: Oct 31, 2025
3 conditions
2 sponsors
1 location
NCT06239220
PD-L1 t-haNK, N-803 IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC
PHASE2
Recruiting
25 participants
Started: Feb 16, 2024 · Completed: Jan 31, 2027
6 conditions
2 sponsors
2 locations
NCT06007976
LLLT to Reduce Low Back Pain
NA
Recruiting
60 participants
Started: Feb 16, 2024 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT06281509
Palmaris Longus Muscle and Dupuytren
NA
Recruiting
240 participants
Started: Feb 16, 2024 · Completed: Jun 1, 2025
1 condition
1 sponsor
1 location
NCT06261216
Association Between Lifetime Physical Activity and Exercise and the Development of Wild-type Transthyretin Amyloid Cardiomyopathy
N/A
Recruiting
189 participants
Started: Feb 16, 2024 · Completed: May 31, 2025
2 conditions
2 sponsors
1 location
NCT05901519
A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
PHASE2
Recruiting
20 participants
Started: Feb 16, 2024 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT06281366
Diamine Oxidase and Adverse Pregnancy Outcomes
N/A
Recruiting
75 participants
Started: Feb 16, 2024 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04706013
Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency
PHASE3
Recruiting
15 participants
Started: Feb 16, 2024 · Completed: Nov 30, 2026
1 condition
1 sponsor
7 locations
NCT05835037
Effect of Zinc on Glucose Homeostasis
PHASE4
Recruiting
200 participants
Started: Feb 16, 2024 · Completed: Jul 31, 2028
2 conditions
1 sponsor
1 location
NCT05910619
Transcranial Pulse Stimulation of the Brain
NA
Recruiting
20 participants
Started: Feb 16, 2024 · Completed: Jul 7, 2026
2 conditions
1 sponsor
1 location
NCT06230016
Adhesion of Children and Adolescents Treated for Cancer to Personalized Support in Adapted Physical Activity Program
N/A
Recruiting
48 participants
Started: Feb 16, 2024 · Completed: Jan 31, 2026
2 conditions
2 sponsors
1 location
NCT05853575
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
PHASE2
Recruiting
200 participants
Started: Feb 16, 2024 · Completed: Jul 30, 2026
3 conditions
1 sponsor
120 locations
NCT06085716
Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers
PHASE2/PHASE3
Recruiting
240 participants
Started: Feb 16, 2024 · Completed: Aug 31, 2029
2 conditions
1 sponsor
1 location
NCT06311058
Protein Supplementation After ACL Surgery
NA
Recruiting
102 participants
Started: Feb 16, 2024 · Completed: Dec 1, 2027
1 condition
1 sponsor
1 location
NCT06270641
Increasing Physical Activity for Adults With Multiple Sclerosis (MS)
NA
Recruiting
106 participants
Started: Feb 16, 2024 · Completed: Sep 30, 2026
3 conditions
1 sponsor
1 location
NCT06208345
Early Life Intervention in Pediatrics Supported by E-health
NA
Recruiting
148 participants
Started: Feb 16, 2024 · Completed: Dec 31, 2028
7 conditions
2 sponsors
1 location
NCT07191223
Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in France
N/A
Recruiting
100 participants
Started: Feb 16, 2024 · Completed: Feb 16, 2026
1 condition
1 sponsor
1 location
NCT06121011
A Global Prospective Observational Registry of Patients With Pompe Disease
N/A
Recruiting
500 participants
Started: Feb 16, 2024 · Completed: Dec 20, 2034
1 condition
1 sponsor
40 locations
NCT06336382
Tau Biomarkers in Late-onset Psychosis (LOP)
N/A
Recruiting
16 participants
Started: Feb 16, 2024 · Completed: Jun 30, 2027
2 conditions
2 sponsors
1 location
NCT06280677
Aurora Test for ART Donor Patients (AURORA-Donor)
N/A
Recruiting
160 participants
Started: Feb 16, 2024 · Completed: Sep 30, 2026
1 condition
3 sponsors
1 location
NCT06328088
Vegetarian Versus Non Vegetarian Based Diet in the Recurrence of Hepatic Encephalopathy in Patients With Cirrhosis: An Open Label Pilot Study
N/A
Recruiting
40 participants
Started: Feb 16, 2024 · Completed: Oct 16, 2024
1 condition
1 sponsor
1 location
NCT06157866
Cognitive Training to Enhance Brain Concordance During Acupuncture
NA
Recruiting
100 participants
Started: Feb 16, 2024 · Completed: Jun 30, 2027
1 condition
2 sponsors
3 locations
NCT06091930
A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
PHASE1
Recruiting
70 participants
Started: Feb 16, 2024 · Completed: Sep 10, 2028
6 conditions
1 sponsor
9 locations
NCT06303921
Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503
EARLY_PHASE1
Recruiting
70 participants
Started: Feb 16, 2024 · Completed: Feb 28, 2029
1 condition
1 sponsor
3 locations
NCT06112522
Tirbanubulin (Klisiry®) in the Treatment of Basal Cell Carcinoma
PHASE2
Recruiting
50 participants
Started: Feb 16, 2024 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT06046170
Adaptation and Feasibility of the Community-Based Anxiety Program Tailored for Autism (CAPTA)
NA
Recruiting
60 participants
Started: Feb 16, 2024 · Completed: Dec 31, 2025
5 conditions
3 sponsors
3 locations
NCT06121297
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
PHASE1/PHASE2
Recruiting
12 participants
Started: Feb 16, 2024 · Completed: Dec 31, 2027
2 conditions
1 sponsor
22 locations
NCT06264804
Risk Factors for Progressive Suction Loss in Corneal Refractive Surgery
N/A
Recruiting
800 participants
Started: Feb 16, 2024 · Completed: Dec 1, 2024
1 condition
1 sponsor
1 location
NCT06120140
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
PHASE2
Recruiting
300 participants
Started: Feb 16, 2024 · Completed: Jan 31, 2032
1 condition
1 sponsor
93 locations
NCT06262360
Changes in Pulmonary Ventilation Distribution Assessed by Electrical Impedance Tomography in Healthy Children Under General Anesthesia
NA
Recruiting
60 participants
Started: Feb 16, 2024 · Completed: Sep 30, 2024
1 condition
1 sponsor
1 location
NCT06014255
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
PHASE2
Recruiting
219 participants
Started: Feb 16, 2024 · Completed: Mar 1, 2029
1 condition
2 sponsors
5 locations
NCT06262165
Evaluation of Liver Damage in Patients With Anorexia Nervosa by Blood Biomarker Analysis
N/A
Recruiting
50 participants
Started: Feb 16, 2024 · Completed: Dec 15, 2032
1 condition
1 sponsor
1 location
NCT06247358
Frailty, Physical Capacity and Lung Function in Postoperative Cardiac Surgery Patients
N/A
Recruiting
200 participants
Started: Feb 16, 2024 · Completed: Oct 10, 2026
4 conditions
1 sponsor
1 location
NCT06321978
Mepilex Border Flex Utilization Pilot Spain
N/A
Recruiting
40 participants
Started: Feb 16, 2024 · Completed: May 31, 2024
1 condition
1 sponsor
1 location
NCT06244485
A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors
PHASE1
Recruiting
210 participants
Started: Feb 16, 2024 · Completed: Nov 1, 2028
1 condition
1 sponsor
38 locations
NCT06711861
Multicenter Retrospective Study on Streptobacillus Moniliformis Infections in France
N/A
Recruiting
20 participants
Started: Feb 16, 2024 · Completed: Feb 16, 2025
1 condition
1 sponsor
1 location
NCT06222749
Oxytocin and Reward Processing in Women
NA
Recruiting
100 participants
Started: Feb 16, 2024 · Completed: Dec 31, 2026
2 conditions
4 sponsors
1 location
NCT06278545
Trial Evaluating Modified FOLFIRINOX and Modified FOLFOX in the Treatment of Locally Advanced or Metastatic Small Bowel Adenocarcinoma
PHASE2
Recruiting
130 participants
Started: Feb 16, 2024 · Completed: Feb 28, 2029
1 condition
1 sponsor
1 location
NCT06051240
Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy
PHASE2
Recruiting
84 participants
Started: Feb 16, 2024 · Completed: Aug 31, 2033
7 conditions
2 sponsors
2 locations
NCT06049082
A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency
PHASE1
Recruiting
15 participants
Started: Feb 15, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
3 locations
NCT05836896
A Phase I Trial to Establish the Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric Antigen Receptor (CAR) T-cells in Patients With Relapsed and Refractory B-cell Malignancies
PHASE1
Recruiting
16 participants
Started: Feb 15, 2024 · Completed: Jun 30, 2027
5 conditions
2 sponsors
1 location
NCT06161506
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
PHASE2
Recruiting
41 participants
Started: Feb 15, 2024 · Completed: Mar 1, 2026
3 conditions
1 sponsor
1 location
NCT06298409
Evaluating the Effect Of Rifaximin on the Gut Microbiota and Metabolome in SIBO Using CapScan®
PHASE1
Recruiting
34 participants
Started: Feb 15, 2024 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT06394011
Study of VA Combined With HAAG Regimen in Newly Diagnosed Intermediate and High-risk AML Patients
PHASE2
Recruiting
60 participants
Started: Feb 15, 2024 · Completed: Dec 30, 2026
2 conditions
1 sponsor
1 location
Previous
1
More pages
575
576
577
578
579
580
581
More pages
1333
Next